Yifeng Pharmacy (603939.SH) released the 2023 annual performance report. The company achieved operating income of 2 during the reporting period...
Zhitong Finance App News, Yifeng Pharmacy (603939.SH) released the 2023 annual performance report. During the reporting period, the company achieved operating income of 22.588 billion yuan, an increase of 13.59%; net profit attributable to shareholders of listed companies was 1,412 billion yuan, up 11.9% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1,362 billion yuan, an increase of 10.92% year on year; basic income per share was 1.4 yuan. At the same time, the company plans to distribute a cash dividend of 0.50 yuan (tax included) per share to all shareholders. At the same time, the increase was converted to capital provident funds The share capital method transfers 0.20 shares per share to all shareholders, and no bonus shares are given.